Research spans inflammatory bowel disease and PSC, critical care nephrology, and ICU outcomes. Works with Brazilian multicenter real-world cohorts, machine-learning risk prediction, and point-of-care ultrasound to personalize care, assess biologic therapies, and clarify acid-base and COVID-19 complications.